# "Comparison of Intra-articular of 0.2% Ropivacaine vs. 0.75% Ropivacaine in Postoperative of Knee Arthroscopy"

> **NCT05807945** · PHASE4 · COMPLETED · sponsor: **Paola M Zamora Munoz** · enrollment: 70 (actual)

## Conditions studied

- Knee Arthroscopy
- Acute Pain

## Interventions

- **DRUG:** Ropivacaine 0.75% Injectable Solution
- **DRUG:** Ropivacaine 0.2% Injectable Solution

## Key facts

- **NCT ID:** NCT05807945
- **Lead sponsor:** Paola M Zamora Munoz
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-04-01
- **Primary completion:** 2023-02-01
- **Final completion:** 2023-02-01
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2024-10-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05807945

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05807945, ""Comparison of Intra-articular of 0.2% Ropivacaine vs. 0.75% Ropivacaine in Postoperative of Knee Arthroscopy"". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05807945. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*